Here’s one analyst’s take on the coronavirus drugs for today and the future By: MarketWatch March 18, 2020 at 05:33 AM EDT Analysts at Bernstein Research in a comprehensive note discussed what approaches are worth keeping an eye on. Read More >> Related Stocks: AbbVie Biontech Se ADR Gilead Sciences Gsk Plc ADR Inovio Pharma Johnson & Johnson Moderna Inc Novavax Inc Regeneron Pharmaceuticals